UCSF-led Team Shares Details of Nanopore-Based Viral Detection Assay, Analysis System | GenomeWeb

NEWYORK (GenomeWeb) – A University of California, San Francisco-led team has completed a proof-of-principle study on a sequencing test and analysis pipeline for detecting viral pathogens, such as the Ebola virus, in clinical samples that they believe could help researchers in resource-poor settings diagnose infections quickly and relatively inexpensively.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.